raloxifene hydrochloride has been researched along with Injuries, Spinal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Minshall, ME; Moses, KH; Shen, W; Silverman, SL; Xie, S | 1 |
| Dijkmans, BA; Lems, WF | 1 |
1 review(s) available for raloxifene hydrochloride and Injuries, Spinal
| Article | Year |
|---|---|
[Effect of anti-osteoporosis agents on the incidence of vertebral fractures].
Topics: Alendronate; Bone Density; Calcitonin; Calcium Channel Blockers; Densitometry; Etidronic Acid; Female; Fractures, Bone; Humans; Incidence; Osteoporosis, Postmenopausal; Postmenopause; Radiography; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risedronic Acid; Selective Estrogen Receptor Modulators; Spinal Injuries; Spine | 2000 |
1 trial(s) available for raloxifene hydrochloride and Injuries, Spinal
| Article | Year |
|---|---|
Prevalence of depressive symptoms in postmenopausal women with low bone mineral density and/or prevalent vertebral fracture: results from the Multiple Outcomes of Raloxifene Evaluation (MORE) study.
Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Calcium, Dietary; Cross-Sectional Studies; Depression; Female; Fractures, Bone; Humans; Middle Aged; Osteoporosis, Postmenopausal; Prevalence; Quality of Life; Raloxifene Hydrochloride; Spinal Injuries; Treatment Outcome; Vitamin D | 2007 |